Successful management of persistent macular hole after macular hole surgery with intravitreal triamcinolone acetonide: A case report

Sen, Alok; Kohli, Gaurav Mohan; Mitra, Amlan Kumar; Talwar, Dinesh

doi:10.4103/ijo.ijo_1511_19

Cited by 5 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Favourable response after using IVB in our case substantiates the probable cause could be related to retinal edema secondary to either ischemia or surgically induced inflammation. Intravitreal triamcinolone acetonide is shown to be useful in management of persistent macular hole secondary to inflammatory ME after a primary macular hole surgery (Sen et al, 2020).…”

Section: Discussionmentioning

confidence: 99%

Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation

Zangmo,

Jayanna,

Shanmugam

2023

Nep J Oph

View full text Add to dashboard Cite

Background: Aetiology for non-closure of full-thickness macular hole (FTMH) becomes crucial in determining the method of effective mode of intervention. Association of epiretinal proliferation (ERP) along with full-thickness macular hole (FTMH) have shown poorer anatomic and visual outcomes after surgical intervention. Various surgical techniques have been described in literature for treatment of persistent MH. Case: We report a A 60-year-old female patient with FTMH secondary to branched retinal vein occlusion (BRVO) initially associated with ERP. Observations: She was successfully managed by treating with combination of intravitreal injection of off label bevacizumab (Avastin) (1.25 mg/0.05 ml) and pure gas of SF6 (1 cc) under topical anaesthesia after an initial surgical intervention. Conclusion: Presence of ERP in retinal vein occlusion cases needs closer and frequent follow up. IVB can be used as an adjunct in treating secondary MH.

show abstract

Section: Discussionmentioning

confidence: 99%

Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation

Zangmo,

Jayanna,

Shanmugam

2023

Nep J Oph

View full text Add to dashboard Cite

show abstract

“…Most recently, Sen et al [ 80 ] raised the opposite opinion. They thought that apart from the anti-inflammatory role which brought down the retinal edema, TA acts as a temporary tamponade.…”

Section: Surgical Factorsmentioning

confidence: 99%

Factors Associated with Anatomic Failure and Hole Reopening after Macular Hole Surgery

Jin

Shi

et al. 2021

Journal of Ophthalmology

View full text Add to dashboard Cite

A macular hole (MH), particularly an idiopathic macular hole (IMH), is a common cause of central vision loss. Risk factors for nonidiopathic MH include high myopia, cystoid macular edema, inflammation, and trauma. MH is primarily diagnosed using slit-lamp microscopy and optical coherence tomography (OCT). Half of the patients with stage I MHs are treated conservatively and may show spontaneous resolution. The main treatment methods for MHs currently include vitrectomy and stripping of the internal limiting membrane (ILM). However, in some patients, surgery does not lead to anatomical closure. In this review, we summarize the factors influencing the anatomical closure of MHs and analyze the potential underlying mechanisms.

show abstract

Treatment of Failure of Macular Hole Closure due to Post-Vitrectomy Macular Edema Using Sub-Tenon Triamcinolone Acetonide Injection: A Case Report

Haraguchi,

Wakuta,

Ariyoshi

et al. 2024

Case Rep Ophthalmol

View full text Add to dashboard Cite

Introduction: Post-vitrectomy cystoid macular edema (CME) can lead to failure of macular hole (MH) closure. We report 2 cases of failure of MH closure due to post-vitrectomy CME, which were successfully treated using sub-Tenon triamcinolone acetonide (STTA) injection. Case Presentations: Case 1 involved a 72-year-old male patient with a Gass Stage 3 MH in the right eye. He underwent pars plana vitrectomy (PPV), internal limiting membrane translocation, and sulfur hexafluoride (SF6) gas injection with cataract surgery in his right eye. The MH did not close postoperatively; further, CME developed at the edge of the MH. Accordingly, the patient underwent an STTA injection. Approximately 2 weeks after the STTA injection, the CME disappeared and the MH closed, which has remained closed 1 year after PPV. Case 2 involved a 78-year-old female patient with Gass Stage 3 MH in the left eye. The patient underwent the same surgical procedure as that performed in case 1. Further, she presented with failure of MH closure caused by CME; therefore, an STTA injection was performed. Approximately 6 weeks after STTA injection, the CME disappeared and the MH closed; further, there was maintained improvement of best-corrected visual acuity for 6 months. Conclusions: STTA injection could be considered before reoperation in cases involving failure of MH closure due to postoperative CME.

show abstract

Successful management of persistent macular hole after macular hole surgery with intravitreal triamcinolone acetonide: A case report

Cited by 5 publications

References 8 publications

Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation

Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation

Factors Associated with Anatomic Failure and Hole Reopening after Macular Hole Surgery

Treatment of Failure of Macular Hole Closure due to Post-Vitrectomy Macular Edema Using Sub-Tenon Triamcinolone Acetonide Injection: A Case Report

Contact Info

Product

Resources

About